Dublin-based firm Actavis, one of the world’s largest generic-drugs makers by market value, has agreed to buy Forest Laboratories for about $25bn (€18bn).

Generic drug maker Actavis has agreed to acquire Dublin headquartered Warner Chilcott for about $5bn (€3.9bn) excluding net debt in a deal to expand in women’s health and urology.